Business Description
Vitrafy Life Sciences Ltd
ISIN : AU0000361297
Description
Vitrafy Life Sciences Ltd developed a range of proprietary smart cryopreservation hardware devices and Lifechain, an integrated, cloud-based software platform, to provide a complete, vertically integrated cryopreservation solution to retain the quality of cryopreserved biomaterials. The company devices includes Vitrafy's Smart Cryopreservation Device; Vitrafy's Smart Thawing Device and Vitrafy's Smart Packaging.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 65.33 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 37.19 | |||||
Beneish M-Score | -5.75 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -96.3 | |||||
3-Year EPS without NRI Growth Rate | -82.5 | |||||
3-Year FCF Growth Rate | -25.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 11.77 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 586 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.77 | |||||
9-Day RSI | 41.41 | |||||
14-Day RSI | 45.21 | |||||
3-1 Month Momentum % | 49.8 | |||||
6-1 Month Momentum % | 71.95 | |||||
12-1 Month Momentum % | 89.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 13.47 | |||||
Quick Ratio | 13.47 | |||||
Cash Ratio | 13.26 | |||||
Days Sales Outstanding | 1098.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.09 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -28110.61 | |||||
Net Margin % | -21440.91 | |||||
EBITDA Margin % | -24780.3 | |||||
FCF Margin % | -17331.82 | |||||
OCF Margin % | -17331.82 | |||||
ROE % | -49.87 | |||||
ROA % | -46.39 | |||||
ROIC % | -1138.22 | |||||
ROC (Joel Greenblatt) % | -2676.8 | |||||
ROCE % | -57.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2810 | |||||
PB Ratio | 8.29 | |||||
Price-to-Tangible-Book | 8.26 | |||||
EV-to-EBIT | -11.71 | |||||
EV-to-EBITDA | -11.81 | |||||
EV-to-Revenue | 2927.17 | |||||
EV-to-FCF | -16.69 | |||||
| Price-to-Net-Current-Asset-Value | 8.52 | |||||
| Price-to-Net-Cash | 8.52 | |||||
Earnings Yield (Greenblatt) % | -8.54 | |||||
FCF Yield % | -5.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vitrafy Life Sciences Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.066 | ||
| EPS (TTM) (A$) | -0.222 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 55.71 | ||
| 14-Day RSI | 45.21 | ||
| 14-Day ATR (A$) | 0.181985 | ||
| 20-Day SMA (A$) | 2.9685 | ||
| 12-1 Month Momentum % | 89.26 | ||
| 52-Week Range (A$) | 1.16 - 3.87 | ||
| Shares Outstanding (Mil) | 76.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vitrafy Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vitrafy Life Sciences Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vitrafy Life Sciences Ltd Frequently Asked Questions
What is Vitrafy Life Sciences Ltd(ASX:VFY)'s stock price today?
The current price of ASX:VFY is A$2.81. The 52 week high of ASX:VFY is A$3.87 and 52 week low is A$1.16.
When is next earnings date of Vitrafy Life Sciences Ltd(ASX:VFY)?
The next earnings date of Vitrafy Life Sciences Ltd(ASX:VFY) is .
Does Vitrafy Life Sciences Ltd(ASX:VFY) pay dividends? If so, how much?
Vitrafy Life Sciences Ltd(ASX:VFY) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Vitrafy Life Sciences Partners with Vitalant Innovation Center to Advance Next-Generation Frozen Red Blood Cell Platform as Legacy Technology Reaches End of Life | 2026-06-02 |
Articles on Vitrafy Life Sciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers